大博医疗科技股份有限公司2025年半年度报告全文 大博医疗科技股份有限公司 大博医疗科技股份有限公司2025年半年度报告全文 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司负责人林志雄、主管会计工作负责人陈丹荷及会计机构负责人(会计 主管人员)陈丹荷声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 本报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承诺。 投资者及相关人士均应对此保持足够的风险认识，并且应当理解计划、预测 与承诺之间的差异。 公司已在本报告中详细描述未来将面临的主要风险及应对措施，详情请 查阅本报告"第三节 管理层讨论与分析"之"十、公司面临的风险和应对措 施"部分，请投资者注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 大博医疗科技股份有限公司2025年半年度报告全文 大博医疗科技股份有限公司2025年半年度报告全文 一、载有公司法定代表人、主管会计工作负责人、会计机构负责人签名并盖章的会计报表。 ...

Core Viewpoint - Dabo Medical's stock closed at 43.76 yuan, marking a 1.30% increase, with a rolling PE ratio of 45.50, the lowest in 669 days, and a total market capitalization of 18.117 billion yuan [1] Company Summary - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, with key products including intramedullary nails, hollow nails, ordinary plates, locking plates, external fixators, bone needles, spinal fixation devices, and various joint prostheses [1] - For Q1 2025, Dabo Medical reported revenue of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04%, with a gross profit margin of 69.64% [1] Industry Summary - The average PE ratio for the medical device industry is 54.55, with a median of 37.54, positioning Dabo Medical at 84th in the industry ranking [1] - The total market capitalization of the industry averages 113.96 billion yuan, with Dabo Medical's market cap at 18.117 billion yuan [2]

Company Overview - Dabo Medical's closing price on May 26 was 37.68 yuan, down 1.13%, with a rolling PE ratio of 39.18 times and a total market capitalization of 15.6 billion yuan [1] - The company ranks 81st in the medical device industry, which has an average PE ratio of 48.92 times and a median of 35.68 times [1][2] - Dabo Medical specializes in the production, research, and sales of high-value medical consumables, including a wide range of orthopedic products [1] Financial Performance - In the first quarter of 2025, Dabo Medical reported revenue of 550 million yuan, a year-on-year increase of 28.80%, and a net profit of 103 million yuan, up 67.04% year-on-year, with a gross profit margin of 69.64% [1] Capital Flow - On May 26, Dabo Medical experienced a net outflow of 7.68 million yuan in principal funds, with a total outflow of 16.74 million yuan over the past five days [1]